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Background & objectives: Tuberculosis (TB) is a major health problem in the developing world. In
this preliminary study, we report the effect of antituberculosis treatment (ATT) on cardiopulmonary
responses to exercise in patients with miliary tuberculosis (MTB).
Methods: The prospective study of cardiopulmonary responses to exercise in patients with MTB
within one month of starting (n=14), on completion of ATT (n=7) and in 15 healthy subjects using
the incremental exercise test was performed on a bicycle ergometer.
Results: In MTB patients, mean body mass index (BMI), exercise duration (3.1 vs 4.6 min), work
load (63 vs 91.4 watts), resting tachycardia, tachypnoea and the mean oxygen saturation improved
significantly (P<0.05) with ATT. Mean oxygen consumption (V. O2) at anaerobic threshold (546.7
vs 580.9 ml/min) and maximum exercise (1008.1 vs 1022 ml/min) were similar before and after
ATT. In MTB patients, post-treatment mean body weight, BMI, resting heart rate, respiratory
rate and oxygen saturation during maximum exercise were similar, but exercise duration (4.6 vs
6.2 min, P<0.05), work load (91.4 vs 145.5 watts, P<0.05), V. O2 and oxygen pulse were significantly
lower as compared to healthy subjects.
Interpretation & conclusion: In MTB patients, though there was significant improvement in clinical
parameters, functional abnormalities persisted on exercise testing after completion of ATT. As
most patients with MTB are young and economically active, these observations obviously have
long-term implications for these individuals.
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Tuberculosis (TB) continues to be an important
communicable disease in the world and has been
declared a global emergency by World Health
Organization1-3. It affects the young and economically
productive segment of the population. The emergence
of human immunodeficiency virus (HIV) infection
has made the situation worse4. The abnormalities in
pulmonary function tests and gas exchange in miliary
tuberculosis (MTB) and the trend for improvement
in these parameters with anti-tuberculosis treatment
(ATT) has been reported earlier2. However, to date,
no study has been done to understand the
pathophysiology of exercise limitation in patients
with MTB. In this preliminary study, we evaluated
the relative importance of the cardiovascular and/or
pulmonary responses to exercise in patients with
MTB and the effect of ATT on these parameters.
Material & Methods
Study subjects: The study was done from January
1996 to December 1999 in the Department of
Medicine, All India Institute of Medical Sciences,
New Delhi, and patients were consecutively selected.
The criteria for the diagnosis of MTB included
(i) clinical presentation consistent with a diagnosis
of TB; (ii) classical miliary pattern on the chest
radiograph; (iii) histopathological or microbiological
evidence of tuberculosis; (iv) bilateral diffuse miliary
lesions demonstrated on high resolution computed
tomographic scan (HRCT scan)2. All patients fulfilled
the first three criteria with or without the last
criterion.
Of the 30 MTB patients seen during the study
period, 14 were enrolled who were able to understand
and perform the exercise test. Feeling of well being
to do the exercise as an important criterion, besides
the informed consent of the patient. In fact, feeling
of well being included the “adaptability level” of the
patients to do bicycling with a bicycle ergometer.
These were MTB patients who were chronically
fifteen healthy subjects were enrolled for this study.
Healthy subjects, selected from persons undergoing
medical examination for employment underwent a
baseline incremental exercise test. At this point, it
needs to be appreciated that due to economic
limitations of a resource-limited developing nation
like India, MTB patients are usually very sick and
toxic, when they report for initial evaluation in a
hospital. Therefore, these patients were subjected to
baseline exercise test within the first month of
starting ATT, when they started experiencing a
relative feeling of well-being to perform the test.
We repeated the exercise test in seven patients,
who reported regularly for follow up, on completion
of ATT. The remaining seven patients were from
distant places and after showing clinical
improvement on initial follow up of 2-3 months
started reporting to their local health care providers
for further treatment. All patients received standard
ATT using rifampicin, isoniazid, pyrazinamide,
ethambutol and/or streptomycin for a duration of nine
(n=4) and 12 months (n=3)5. Written informed
consent was taken from both MTB patients and
healthy subjects. Both MTB patients and healthy
subjects were adequately motivated and counseled
to perform the test.
Protocol: The ventilatory parameters were obtained
with the transfer test model C (Morgan, UK). The
measurement of the pulmonary function tests has
already been standardized in the respiratory
laboratory of our hospital2.
With the subject comfortably seated on bicycle
ergometer, an incremental exercise test to the limit
of tolerance was performed. The initial exercise
load was selected depending on the expected
performance of the patient. The subject had to
breathe through a low resistance unidirectional
valve attached to the mouth piece. The inspiratory
port of the valve was connected to a turbine which
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was calibrated to give an electrical signal in terms
of the inspired volume which was constantly
displayed on the instrument panel. The expiratory
port of the unidirectional valve was connected by
flexible large tubing to a mixing chamber to allow
the expired air to enter from the top and flow out
from an opening at the bottom of the chamber. The
mixed expired air concentration of O2 and CO2 was
calculated from the port near the exit pole of the
mixing chamber. All calibrations for O2 and CO2
gas meter, heart rate meter and work load meter
were performed with the help of a computer
(Magna 88,  UK) and appropriate  software
(Wyvern, UK). A time lag was built in the software
to give online display of the O2 consumption,
ventilation and heart rate on the visual display unit
of the computer. The blood pressure recording
was obtained manually with a  mercury
sphygmomanometer every two to three minutes till
the maximal tolerable work load and at the end of
four  minutes  recovery.  The subjects  were
continuously monitored for leaks at the mouth
piece and encouraged to maintain correct cycle
pedaling frequency.
Heart rate (HR) was monitored beat-by-beat from
the R-R interval of the ECG signal. The electric
signals from the above devices underwent analog-
to-digital conversion and were processed by digital
computation for the online breath-by-breath
determination of oxygen uptake (V. O2), CO2 output
(V. CO2), and ventilation (V
.
 E). The data of minute
ventilation (V. E), heart rate, mixed expired O2 and
CO2 concentration, O2 pulse and actual work load in
watts were stored in the computer. The data for the
systemic blood pressure and end tidal CO2
concentration were manually recorded. The results
of ventilatory equivalents of O2 (V
.
 E/V
.
 O2) and CO2
(V. E/V. CO2) and O2 pulse were calculated by the
computer using Wyvern software. The oxygen
saturation was measured with a finger probe
connected to an oximeter (Ohmeda BIOX 3700,
USA).
The anerobic threshold (AT) was measured as
the V
.
 O2 at which: (i) the respiratory exchange ratio
increased abruptly without hyperventilation, and
(ii) the ventilatory equivalent for O2 (V
.
 E/V
.
 O2)
started to increase progressively without an increase
in the ventilatory equivalent for CO2 (V
.
 E/V
.
 CO2).
AT was expressed as absolute value of O2.
The pulmonary parameters before and after
exercise were analyzed as follows: (i) The breathing
reserve (BR), i.e., the unused fraction of the potential
ventilation at maximal work level (1-V. E max/MVV)
where V
.
 E max is the ventilation at maximal exercise
and MVV is the maximal voluntary ventilation at
rest; and (ii) the breathing pattern at rest and during
exercise as measured by changes in respiratory rate.
The cardiovascular oxygen transport capacity during
exercise was estimated in the three groups by: (i) the
analysis of the heart rate reserve (HRR) calculated
as 1-[(HRmax-HRrest) (HRpred max-HRrest], where
HRmax is the heart rate at maximum exercise, HRrest
is the resting heart rate and HRpred max is the
maximum heart rate predicted for age; (ii) the
determination of the AT; and (iii) the maximum
aerobic capacity (V . O2max).
On termination of exercise, the subject was asked
to discontinue pedaling, but continue to breathe
through the mouth piece during the two minute
recovery time. Online data acquisition was continued
for 4 min in order to record the recovery data. On
review of the data, if it appeared that the test was
terminated prematurely because of inadequate effort
and/or evident technical malfunction, a repeat test
after a period of 30 to 45 min was performed.
Statistical analysis: The comparison of healthy
subjects with pre- and post-treatment groups
respectively was done using unpaired t-test. The
effect of ATT was evaluated using Wilcoxon’s
ranked-sum test. A value of P<0.05 was considered
significant.
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Results
Demographic characteristics: The characteristics of
the study population are given in Table I. The
exercise test was repeated in 7 patients on completion
of ATT (4 patients at nine months and 3 patients at
11 months). All healthy subjects had normal
complete blood count and chest radiograph.
Pre-treatment MTB patients and healthy subjects:
The mean duration of exercise (2.9 vs 6.2 min) and
maximum work load (57 vs 145.5 watts) was
significantly (P<0.05) lower and resting tachycardia
(111 vs 86.5 bpm) significantly higher (P<0.05) in
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Table I. Demographic characteristics in miliary tuberculosis
(MTB) patients (pre & post-treatment) and healthy subjects
Group (n) Age (yr) Haemoglobin
(M:F)      (g/dl)
MTB patients (14) 27.1 ± 3.5 12.7 ± 2.2
(6:8)
Healthy subjects (15) 25.7 ± 3.9 13.4 ± 0.8
(7:8)
Pre-treatment* (7) 12.5 ± 1.9
(5:2) 28.7 ± 11.3
Post-treatment* (7) 13.9 ± 1.5
(5:2)
Values are mean ± SD
Exercise test was repeated in 7 patients, who reported regularly
for follow up, on completion of anti-tuberculosis therapy
Table II. Cardiovascular and respiratory variables in pre- and post-treatment in miliary patients and normal subjects at rest and
maximal exercise
Variable Healthy subjects Pre-treatment Post-treatment
(n=15) (n=14) (n=7)
Weight (kg) 59 ± 9 47 ± 12* 56.7 ± 16.5
Body mass index (kg/m2) 20.6 ± 2.8 18.4 ± 3.7 21.8 ± 5
Duration of exercise (min) 6.2 ± 1.4 2.9 ± 0.6* 4.6 ± 1.1*
Maximum work load (watts) 145.5 ± 29.9 57 ± 25.3* 91.4 ± 48.3*
Heart rate (beats/min):
Rest 86.5 ± 15.3 111.1 ± 16.6* 98 ± 13.3
Maximum exercise 179.6 ± 11.7 149.9 ± 17.8* 161.6 ± 16.5*
V
.
O2 (ml / min):
Rest 289.1 ± 35.4 235.7 ± 79.8* 175.3 ± 74.4
Maximum exercise 2218 ± 507.4 935 ± 407.3* 1022 ± 379.3*
AT (ml/min) 1254 ± 294 495.2 ± 259.5* 580.9 ± 153.8*
O2 pulse (ml/beat):
Rest 3.1 ± 0.6 1.9 ± 0.8* 2.1 ± 0.7*
Maximum exercise 11.7 ± 2.1 6.4 ± 3.2* 6.5 ± 2.9*
Heart rate reserve (%) 7.5 ± 5.0 36.7 ± 15.5* 25.6 ± 13.8*
Respiratory rate (frequency/min):
Rest 20.1 ± 5.4 26.1 ± 6.5* 19 ± 5.1
Maximum exercise 39.8 ± 10 45.5 ± 12 37.3 ± 9.5
V
.
 E(l/min):
Rest 11.5 ± 3 8.9 ± 3.7* 9.0 ± 3.5
Maximum exercise 72.2 ± 15.3 35.7 ± 15.1* 35.4 ± 18.8*
Breathing reserve (%) 38.4 ± 14.8 53.8 ± 25.2* 53.8 ± 25.2*
Oxygen saturation (%):
Rest 98.8 ± 0.7 96.9 ± 1.1* 96.7 ± 1.1
Maximum exercise 98.3 ± 0.8 93.8 ± 2.8* 95.6 ± 1.8*
Values are mean ± SD
V
.
 O2 , oxygen consumption; AT, anaerobic threshold; V
.
 E
 
, minute ventilation; *P<0.05 compared to normal subjects
}
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Table III. Cardiovascular and respiratory variables in miliary
TB patients before and after anti-tuberculosis treatment at rest
and maximal exercise
Variable Pre-treatment Post-treatment
(n=7) (n=7)
Weight (kg) 49 ± 16 56.7 ± 16.5*
Body mass index (kg/m2) 18.4 ± 4.5 21.8 ± 5*
Duration of exercise (min) 3.1 ± 0.7 4.6 ± 1.1*
Maximum work load (watts) 63 ± 31.2 91.4 ± 48.3*
Heart rate (beats/min):
Rest 113.9 ± 19.4 98 ± 13.3*
Maximum exercise 157.3 ± 17.4 161.6 ± 16.5
V
.
O2 (ml/min):
Rest 273.1 ± 97.2 175.3 ± 74.4*
Maximum exercise 1008.1 ± 357.4 1022 ± 379.3
AT (ml/min) 546.7 ± 271.8 580.9 ± 153.8
O2 pulse (ml/beat):
Rest 2.2 ± 0.9 2.1 ± 0.7
Maximum exercise 6.6 ± 2.9 6.5 ± 2.9
Heart rate reserve (%) 29.1 ± 13.5 25.6 ± 13.8
Respiratory rate(frequency/min):
Rest 26.6 ± 8.4 19 ± 5.1*
Maximum exercise 48.3 ± 10.6 37.3 ± 9.5*
V
.
 E(l/min):
Rest 8.3 ± 2.6 9.0 ± 3.5
Maximum exercise 36.1 ± 13.6 35.4 ± 18.8
Breathing reserve (%) 62.8 ± 24.7 65.1 ± 29.3
Oxygen saturation (%):
Rest 96.7 ± 1.1 96.7 + 1.1
Maximum exercise 93 + 3.2 95.6 ± 1.8*
Values are mean ± SD
V
.
O2,  oxygen consumption; AT, anaerobic threshold;
 V
.
 E, minute ventilation; *P<0.05 compared to pre- treatment
pre-treatment MTB patients as compared to healthy
subjects. Likewise, at maximum exercise, the heart
rate achieved by patients with MTB was significantly
lower than healthy subjects. At rest, AT and
maximum exercise, MTB patients had a significantly
(P<0.05) lower oxygen uptake (V. O2) as compared to
control subjects. The rest values for oxygen pulse
were lower in the MTB group as compared to healthy
subjects. At maximum exercise, MTB patients
achieved significantly lower V
.
E than healthy
subjects (35.7 vs 72.2 l/min) and oxygen saturation
was significantly lower in MTB patients as compared
to healthy subjects (93.8 vs 98.3%) (Table II).
Effect of treatment on exercise performance: With
ATT, mean body weight and body mass index (BMI,
kg/m2) improved significantly (P<0.05) (Table III).
The mean haemoglobin was similar before and after
treatment (Table I).
There was significant improvement in the
duration of exercise and work load and a significant
reduction in the resting tachycardia after treatment
(P<0.05). However, there was no statistically
significant difference in the mean heart rate at
maximum exercise and the mean heart rate reserve
(P=0.17) before and after ATT (Table III). ATT
resulted in a significant (P<0.05) reduction in the
V
.
 O2 at rest. However, V
.
 O2 at maximum exercise was
similar before and after treatment. The AT was also
similar before and after treatment. There was no
change in rest and maximum exercise values for
oxygen pulse after treatment. The pattern of O2 pulse
response to incremental exercise before and after
treatment was similar (Table III).
There was a statistically significant improvement
in the resting respiratory rate and a reduction in the
respiratory rate at maximum exercise (P<0.05) with
ATT. The mean V
.
 E at rest and maximal exercise,
mean breathing reserve and mean oxygen saturation
at rest were similar before and after treatment. Mean
oxygen saturation (%) at maximum exercise
significantly improved after ATT (P<0.05)
(Table III).
Post-treatment MTB patients and healthy subjects:
The mean body weight and BMI of post-treatment
MTB patients were similar to the observations in
healthy subjects. However, the duration of exercise
(P<0.05) and work load (P<0.05) were significantly
less in MTB patients after treatment compared with
healthy subjects. The resting heart rate was similar
in treated MTB patients and healthy subjects. At
maximum exercise, the heart rate achieved by post-
treatment MTB patients was significantly lower as
compared to healthy subjects (P<0.05). Moreover,
post-treatment MTB patients achieved a significantly
higher heart rate reserve as compared to healthy
subjects (P<0.05) (Table II).
V
.
 O2 at rest, AT and maximum exercise in treated
MTB patients was significantly lower than healthy
subjects. The resting oxygen pulse was also lower in
post-treatment MTB patients as compared to healthy
subjects. Moreover, the treated patients interrupted
exercise with a higher breathing reserve as compared
to healthy subjects. After treatment, the resting
respiratory rate and respiratory rate at maximal
exercise was comparable to healthy subjects. There
was a significant improvement in the oxygen
saturation during maximum exercise in MTB patients
after ATT, but was still lower as compared to healthy
subjects (Table II).
Discussion
We appreciate the limitations imposed by the
relatively small sample size of our study. In fact, to
the best of our knowledge the pathophysiology of
exercise limitation in MTB patients has not been
reported earlier in the literature. Moreover, MTB
patients constitute less than 1 per cent of the TB
burden in the community and these patients are
relatively sick also. Therefore, the enormous
logistical constraints of a similar longitudinal study
with a large sample size in India also need to be taken
into consideration. Our study is a preliminary
contribution in this direction.
The changes in pulmonary function tests have
been studied earlier in MTB patients2. In the present
study, anaemia does not appear to be a confounding
factor in the interpretation of cardiopulmonary
abnormalities as patients with MTB (before and after
treatment) and healthy subjects had similar normal
haemoglobin values.
Though MTB patients showed significant
improvement in exercise duration after ATT, it was
still less as compared to healthy subjects. However,
the significant improvement in their body weight and
the fact that post-treatment mean body weight and
BMI of MTB patients were almost the same as in
healthy subjects suggests that weight is also not a
confounding factor in the interpretation of
cardiopulmonary abnormalities.
In MTB patients, resting tachycardia and
tachypnoea improved following treatment and were
similar to the observations in healthy subjects.
Moreover, after ATT, there was improvement in
hypoxaemia during exercise in patients with MTB.
However, treated MTB patients had reduced AT
compared to healthy subjects. The lower AT in
patients with lung disease may be due to reduced
oxygen transfer because of diffusion abnormalities
in the lungs resulting in reduced oxygen carrying
capacity and lower oxygen availability at the tissue
mitochondria level. Though lung diseases classically
do not have decreased AT, the reduced AT in MTB
patients may also be due to a low cardiac output
state6. Since clinically no patient had any
cardiac abnormality, cardiac evaluation with
echocardiography was not included in the protocol
of our study. It can be postulated that low cardiac
output in MTB patients may be due to early cor-
pulmonale due to extensive miliary involvement of
lung or direct involvement of heart due to TB. A low
AT may be an important compensatory mechanism
and the relative contribution to energy output in MTB
patients by anaerobic mechanisms may be greater.
On exercise, post-treatment MTB patients had
significantly reduced oxygen consumption as
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compared to healthy subjects. The reduced V. O2max
may be the result of reduced oxygen carrying capacity
in MTB patients due to the diffusion abnormalities
in the lungs. The fact that oxygen consumption did
not improve with treatment may be due to poor
exercise tolerance as well as subtle changes in the
alveolocapillary membrane and/or ventilation
perfusion mismatching and/or factors related to
capillary blood flow.
The oxygen pulse plateau was significantly less
steep in MTB patients before and after treatment as
compared to healthy subjects. Before ATT, lower
oxygen pulse at rest and maximum exercise may be
due to the marked resting tachycardia. Since the
tachycardia settled after ATT, this does not seem to
be the plausible explanation as there is no
improvement in the oxygen pulse after therapy. The
low oxygen pulse may again signify lower stroke
volume in these patients. However, it is also
important to appreciate that a low oxygen pulse at
maximum exercise in MTB patients before and after
treatment might be the result of the patient
interrupting the exercise before the cardiovascular
system was maximally stressed rather than
compromised O2 transport. The importance of
deconditioning of muscles due to lack of exercise
when these subjects are ill also needs to be taken
into consideration.
Though V
.
 E max was reduced in treated MTB
patients as compared to healthy subjects, but when
compared with similar work rate, they had a higher
V
.
 E
 
than the healthy subjects. This implies that there
is a higher ventilatory requirement to accomplish the
same work in MTB patients as compared to healthy
subjects and this does not become normal even after
ATT therapy. The breathing reserve was higher in
MTB patients suggesting that they did not stop
exercise due to exhaustion of ventilatory capacity. It
possibly indicates that MTB patients stopped exercise
at a comparatively lower level of ventilation possibly
due to fatigability or these patients were
cardiovascular-limited as also suggested by low
oxygen pulse. The patients with MTB had a higher
heart rate reserve as compared to healthy subjects,
suggesting that they stopped exercise probably due
to poor muscle conditioning.
Interestingly, an earlier study by Sharma et al7
had demonstrated subtle ‘air trapping’ in MTB
patients not only at the time of diagnosis, but it also
persisted on follow up, when these patients had
clinically become asymptomatic after nine to twelve
months of ATT. The subtle air trapping findings were
not appreciated on a plain chest radiograph but
observed only on computed tomography. These air
trapping lesions were not typical of classical
emphysema. The authors had postulated that the
clinical significance of these subtle air trappings
needs to be studied in patients of MTB who were
otherwise ‘asymptomatic’ after treatment7. The
current study possibly explains the clinical
significance of the earlier observations.
In conclusion, though simple clinical parameters
like duration of exercise, resting tachycardia,
tachypnoea and oxygen saturation showed
improvement after anti-TB therapy, there were
significant functional abnormalities on the
cardiopulmonary exercise test. This indicates that
MTB patients, though “clinically” normal following
treatment, have underlying residual cardiopulmonary
limitations, which are unmasked on exercise. As most
patients with TB are young and economically active,
our observations have long-term implications for
these individuals. We believe that exercise studies
at regular intervals after completion of ATT in MTB
patients which also includes simultaneous cardiac
evaluation would clarify further as to whether these
functional abnormalities are static or improve after
a period of time. The issue of exercise training and
muscle deconditioning in MTB patients also needs
critical evaluation and research.
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